Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Feb;75(2):105-107.
doi: 10.1097/FJC.0000000000000782.

Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?

Marco Giuseppe Del Buono  1   2 , Aldo Bonaventura  1   3 , Alessandra Vecchié  1   3 , George F Wohlford  4 , Dave L Dixon  4 , Benjamin W Van Tassel  4 , Antonio Abbate  1
Affiliations
Editorial

Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?

Marco Giuseppe Del Buono et al. J Cardiovasc Pharmacol. 2020 Feb.
No abstract available

PubMed Disclaimer

References

    1. Solomon SD, Rizkala AR, Gong J, et al. Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF trial. JACC Heart Fail. 2017;5:471–482.
    1. Solomon SD, McMurray JJV, Anand IS, et al.; PARAGON-HF Investigators and Committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med. 2019;381:1609–1620.
    1. McMurray JJ, Packer M, Desai AS, et al.; PARADIGM-HF Committees and Investigators. Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF). Eur J Heart Fail. 2013;15:1062–1073.
    1. McMurray JJ, Packer M, Desai AS, et al.; PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004.
    1. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207620Orig1s000.... Accessed July 22, 2015.

Publication types

MeSH terms

LinkOut - more resources